Investor

Fitalent

fitalent.com ↗ ·Madrid ·Early stage ·Actively investing

Fitalent is the corporate venture capital fund of NTT DATA (formerly everis group), based in Madrid, Spain, founded in 2011. It invests in early-stage, technology-based Spanish startups where people and talent are the core asset, operating through three strategic lines launched in 2017: Venture Capital, Corporate Venturing, and Company Builder. The fund has backed around 19 companies including Irisbond, Palobiofarma, SATLANTIS and AbilityPharma.

Portfolio

Team

AUM

n/a

Rounds

Cheque

€150K–750K

SectorsHealth, Enterprise Software, Life Sciences/Biotech, Transportation, Digital Business VC MapCorporate VC

Profile updated 18 Jul 2026

Team

No names on record yet.

Portfolio companies 9

Ability Pharmaceuticals

abilitypharma.com

Company Other Cerdanyola del Vallès

Company Seed Barcelona

Citibeats

citibeats.com

Company Seed Barcelona

Company Seed Santiago de Compostela

Company Seed Barcelona

Spectrapply

Company Seed Oviedo

Funding rounds 4

AbilityPharma · Other · €7M

Clinical-stage biopharma AbilityPharma raised €7M from a European-Canadian syndicate to fully fund the international Phase 2b trial of its o…

2024-03-11

Oncostellae · Other · €500K

Bio & Tech Smart Capital, the Galician life-sciences fund managed by Noso Capital and promoted by Grupo Zendal, invested €500,000 in Oncoste…

2023-07-05

Medibiofarma · Seed · €1.2M

Navarre clinical-stage biotech Medibiofarma, based at the CEIN incubator in Noáin and founded in 2016 by the team behind Palobiofarma, close…

2022-03-15

Boxmotions · Seed · €2.4M

Boxmotions runs an on-demand smart storage service. It closed a €2.4M round co-led by Fitalent (Everis), Castel Capital and Finaves, to laun…

2020-01-10

News & media 3

Published	Article
2024-03-11	AbilityPharma Announces €7 Million Financing Round to Advance Development of its Clinical Phase 2b Autophagy Inducer ABTL0812 in Metastatic Pancreatic Cancer ↗ PR Newswire
2024-02-02	Palobiofarma closes a €7M round with the participation of Inveready, Sodena and the Promotor team ↗ Capital-Riesgo.es (English)
2023-08-24	The Galician biopharmaceutical Oncostellae opens an office at the Barcelona Science Park ↗ AseBio